Boston Scientific (BSX) reported a net loss of $615 million in the fourth quarter due to one-time income tax charge of $842 million. Adjusted earnings came in at $0.34 per share, which improved 13% vs. last year. MedSurg business grew 14% in the fourth quarter raking in $931 million. Check out the highlights: http://alph.st/bcdf4ce8
